These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21165393)

  • 1. Blood levels of inflammatory and destructive biomarkers in coronary atherosclerosis of different severity.
    Ragino YI; Chernjavski AM; Polonskaja YV; Tchimbal SY; Redjkin DA; Semaeva EV; Kashtanova EV; Voevoda MI
    Bull Exp Biol Med; 2010 Oct; 149(5):587-90. PubMed ID: 21165393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of exercise-based cardiac rehabilitation on non-culprit mild coronary plaques in the culprit coronary artery of patients with acute coronary syndrome.
    Kurose S; Iwasaka J; Tsutsumi H; Yamanaka Y; Shinno H; Fukushima Y; Higurashi K; Imai M; Masuda I; Takeda S; Kawai C; Kimura Y
    Heart Vessels; 2016 Jun; 31(6):846-54. PubMed ID: 25896129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inflammatory-destructive biomarkers of atherosclerotic plaques instability. Study of arterial wall and blood].
    Ragino IuI; Cherniavskiĭ AM; Polonskaia IaV; Volkov AM; Kashtanova EV; Tsymbal SIu; Polovnikova EM
    Kardiologiia; 2012; 52(5):37-41. PubMed ID: 22839584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apelin: a potential marker of coronary artery stenosis and atherosclerotic plaque stability in ACS patients.
    Zhou Y; Wang Y; Qiao S
    Int Heart J; 2014; 55(3):204-12. PubMed ID: 24806385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activity of inflammatory-destructive changes in the process of formation of unstable atherosclerotic plaque].
    Ragino IuI; Cherniavskiĭ AM; Polonskaia IaV; Volkov AM; Semaeva EV; Voevoda MI
    Kardiologiia; 2007; 47(9):62-6. PubMed ID: 18260930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease.
    Niccoli G; Cin D; Scalone G; Panebianco M; Abbolito S; Cosentino N; Jacoangeli F; Refaat H; Gallo G; Salerno G; Volpe M; Crea F; De Biase L
    Atherosclerosis; 2016 Mar; 246():214-20. PubMed ID: 26803430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention.
    Robertson L; Grip L; Mattsson Hultén L; Hulthe J; Wiklund O
    J Intern Med; 2007 Dec; 262(6):659-67. PubMed ID: 17927738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision phenotyping, panomics, and system-level bioinformatics to delineate complex biologies of atherosclerosis: rationale and design of the "Genetic Loci and the Burden of Atherosclerotic Lesions" study.
    Voros S; Maurovich-Horvat P; Marvasty IB; Bansal AT; Barnes MR; Vazquez G; Murray SS; Voros V; Merkely B; Brown BO; Warnick GR
    J Cardiovasc Comput Tomogr; 2014; 8(6):442-51. PubMed ID: 25439791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hs-Troponin I Followed by CT Angiography Improves Acute Coronary Syndrome Risk Stratification Accuracy and Work-Up in Acute Chest Pain Patients: Results From ROMICAT II Trial.
    Ferencik M; Liu T; Mayrhofer T; Puchner SB; Lu MT; Maurovich-Horvat P; Pope JH; Truong QA; Udelson JE; Peacock WF; White CS; Woodard PK; Fleg JL; Nagurney JT; Januzzi JL; Hoffmann U
    JACC Cardiovasc Imaging; 2015 Nov; 8(11):1272-1281. PubMed ID: 26476506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal distribution of plaque burden and necrotic core-rich plaques in nonculprit lesions of patients presenting with acute coronary syndromes.
    Wykrzykowska JJ; Mintz GS; Garcia-Garcia HM; Maehara A; Fahy M; Xu K; Inguez A; Fajadet J; Lansky A; Templin B; Zhang Z; de Bruyne B; Weisz G; Serruys PW; Stone GW
    JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S10-8. PubMed ID: 22421223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophil cationic protein: A new biomarker of coronary atherosclerosis.
    Niccoli G; Ferrante G; Cosentino N; Conte M; Belloni F; Marino M; Bacà M; Montone RA; Sabato V; Schiavino D; Patriarca G; Crea F
    Atherosclerosis; 2010 Aug; 211(2):606-11. PubMed ID: 20307883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of atherosclerotic tissue types in single-vessel and intermediate coronary lesions: a cross-sectional study.
    Wang X; Chen Q; Xu Y; Wang Y; Yang Y; Gu M; Xu H; Zhao Y
    Lipids Health Dis; 2017 Mar; 16(1):63. PubMed ID: 28335787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum homocysteine levels with the severity and calcification of coronary atherosclerotic plaques detected by coronary CT angiography.
    Sun Q; Jia X; Gao J; Mou W; Tong H; Wen X; Tian Y
    Int Angiol; 2014 Aug; 33(4):316-23. PubMed ID: 25056163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen in relation to degree and composition of coronary plaque on intravascular ultrasound in patients undergoing coronary angiography.
    Buljubasic N; Akkerhuis KM; Cheng JM; Oemrawsingh RM; Garcia-Garcia HM; de Boer SP; Regar E; van Geuns RM; Serruys PW; Boersma E; Kardys I
    Coron Artery Dis; 2017 Jan; 28(1):23-32. PubMed ID: 27755007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OX40 ligand levels and high-sensitivity C-reactive protein levels in blood from local coronary plaque and the femoral artery in patients with acute coronary syndrome or stable angina.
    Shi JZ; Wang LY; Zhu Y; Zhao CY; Liu W; Jiang SL; You HW; Wang Y; Xu FY; Tang YS; Cui LQ
    J Int Med Res; 2011; 39(4):1275-83. PubMed ID: 21986129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparision of high sensitivity C-reactive protein and matrix metalloproteinase 9 in patients with unstable angina between with and without significant coronary artery plaques.
    Wang LX; Lü SZ; Zhang WJ; Song XT; Chen H; Zhang LJ
    Chin Med J (Engl); 2011 Jun; 124(11):1657-61. PubMed ID: 21740772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in proinflammatory cytokine and destructive metalloproteinase levels during formation of unstable atherosclerotic plaque].
    Ragino IuI; Cherniavskiĭ AM; Polonskaia IaV; Volkov AM; Semaeva EV; Tsymbal SIu; Voevoda MI
    Kardiologiia; 2009; 49(6):43-9. PubMed ID: 19656094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of some hemostasis and endothelial dysfunction factors with probability of presence of vulnerable atherosclerotic plaques in patients with coronary atherosclerosis.
    Ragino YI; Striukova EV; Murashov IS; Polonskaya YV; Volkov AM; Kurguzov AV; Chernjavskii AM; Kashtanova EV
    BMC Res Notes; 2019 Jun; 12(1):336. PubMed ID: 31196144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Collagen fiber pathology in atherosclerotic plaques of the coronary arteries in ischemic heart disease].
    Zhdanov VS; Veselova SP; Drobkova IP; Galakhov IE
    Arkh Patol; 2011; 73(6):3-6. PubMed ID: 22379890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of C-reactive protein to coronary plaque characteristics on grayscale, radiofrequency intravascular ultrasound, and cardiovascular outcome in patients with acute coronary syndrome or stable angina pectoris (from the ATHEROREMO-IVUS study).
    Cheng JM; Oemrawsingh RM; Garcia-Garcia HM; Akkerhuis KM; Kardys I; de Boer SP; Langstraat JS; Regar E; van Geuns RJ; Serruys PW; Boersma E
    Am J Cardiol; 2014 Nov; 114(10):1497-503. PubMed ID: 25248815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.